Literature DB >> 20349408

Warfarin: to use or not to use in chronic kidney disease patients?

Mario Cozzolino1, Vincent Brandenburg.   

Abstract

Is the risk of major bleeding the only reason to be concerned about oral anticoagulant therapy in chronic kidney disease patients? We consider another potential adverse effect of long-term Coumadin use in chronic kidney disease patients as comparably devastating: the threat of inducing creeping vascular calcification.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20349408

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


  6 in total

1.  [Calciphylaxis. Pathogenesis and therapy].

Authors:  N-P Hoff; B Homey
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

Review 2.  From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.

Authors:  Vincent M Brandenburg; Patrick D'Haese; Annika Deck; Djalila Mekahli; Björn Meijers; Ellen Neven; Pieter Evenepoel
Journal:  Pediatr Nephrol       Date:  2015-03-04       Impact factor: 3.714

3.  Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.

Authors:  Christina L Fanola; Deirdre Mooney; Andrew J Cowan; Darae Ko; Emily K Sisson; Lori E Henault; Yorghos Tripodis; Elaine M Hylek
Journal:  Am Heart J       Date:  2016-11-04       Impact factor: 4.749

4.  Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective.

Authors:  Mario Cozzolino; Maria Antonietta Rizzo; Andrea Stucchi; Daniele Cusi; Maurizio Gallieni
Journal:  Ther Adv Chronic Dis       Date:  2012-03       Impact factor: 5.091

Review 5.  Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Authors:  Vincent M Brandenburg; Smeeta Sinha; Paula Specht; Markus Ketteler
Journal:  Pediatr Nephrol       Date:  2014-01-29       Impact factor: 3.714

Review 6.  Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?

Authors:  Marek Saracyn; Dorota Brodowska-Kania; Stanisław Niemczyk
Journal:  ScientificWorldJournal       Date:  2013-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.